Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized Controlled Adaptive Study Comparing COVID-19 Convalescent Plasma (CCP) to Non-immune Plasma to Limit Coronavirus-associated Complications in Hospitalized Patients

NCT04421404 is registered in ClinicalTrials.gov with Priscilla Hsue, MD as lead sponsor.

NCT NCT04421404
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04421404 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized Controlled Adaptive Study Comparing COVID-19 Convalescent Plasma (CCP) to Non-immune Plasma to Limit Coronavirus-associated Complications in Hospitalized Patients
Lead sponsor
Priscilla Hsue, MD
Phase
Phase 2
Overall status
Completed
Start date
June 9, 2020
Completion date
April 30, 2021
Enrollment
34 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

covid-19, sars-cov2